An Knock-in Zebrafish Experimental Model Used in Evaluation of the Amantadine Drug Safety During Early Cardiogenesis

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 Apr 22

PMID 35449877

Authors

Shi Ouyang

Wu-Ming Qin

Yu-Juan Niu

Yong-He Ding

Yun Deng

Affiliations

Soon will be listed here.

Abstract

Background: Drug exposure during gestation or in prematurely born children represents a significant risk to congenital heart disease (CHD). Amantadine is an antiviral agent also effective in the treatment of Parkinson's disease. However, while its potential side effects associated with tetralogy of fallot (ToF) and birth defects were implicated, its underlying etiologic mechanisms of action remain unknown. Here, we report teratogenic effects of amantadine drug during early cardiogenesis through developing a novel zebrafish () knock-in (KI) animal model and explore the underlying mechanisms.

Methods: Homologous recombination (HR) pathway triggered by CRISPR/Cas9 system was utilized to generate an enhanced green fluorescent protein (EGFP) KI zebrafish animal model. Dynamic fluorescence imaging coupled with a whole-mount hybridization (WISH) assay was employed to compare the spatial and temporal expression patterns of the EGFP reporter in the KI animal model with the KI-targeted endogenous gene. Heart morphology and EGFP expression dynamics in the KI animal models were monitored to assess cardiac side effects of different doses of amantadine hydrochloride. Expression of key genes required for myocardium differentiation and left-right (LR) asymmetry was analyzed using WISH and quantitative reverse transcription-PCR (RT-PCR).

Results: A novel EGFP KI line targeted at the ventricular myosin heavy chain ( gene locus was successfully generated, in which EGFP reporter could faithfully recapitulate the endogenous expression dynamics of the ventricle chamber-specific expression of the gene. Amantadine drug treatment-induced ectopic expression of gene in the atrium and caused cardiac-looping or LR asymmetry defects to dose-dependently during early cardiogenesis, concomitant with dramatically reduced expression levels of key genes required for myocardium differentiation and LR asymmetry.

Conclusion: We generated a novel zebrafish KI animal model in which EGFP reports the ventricle chamber-specific expression of gene dynamics that is useful to effectively assess drug safety on the cardiac morphology . Specifically, this study identified teratogenic effects of amantadine drug during early cardiogenesis dose dependent, which could be likely conveyed by inhibiting expression of key genes required for cardiac myocardium differentiation and LR asymmetry.

References

Benson D, Silberbach G, Kavanaugh-McHugh A, Cottrill C, Zhang Y, Riggs S . Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest. 1999; 104(11):1567-73. PMC: 409866. DOI: 10.1172/JCI8154. View

Jin D, Ni T, Hou J, Rellinger E, Zhong T . Promoter analysis of ventricular myosin heavy chain (vmhc) in zebrafish embryos. Dev Dyn. 2009; 238(7):1760-7. PMC: 4102584. DOI: 10.1002/dvdy.22000. View

Embry M, Belanger S, Braunbeck T, Galay-Burgos M, Halder M, Hinton D . The fish embryo toxicity test as an animal alternative method in hazard and risk assessment and scientific research. Aquat Toxicol. 2010; 97(2):79-87. DOI: 10.1016/j.aquatox.2009.12.008. View

Schott J, Benson D, Basson C, Pease W, Silberbach G, Moak J . Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science. 1998; 281(5373):108-11. DOI: 10.1126/science.281.5373.108. View

Luo J, Bian W, Liu Y, Huang H, Yin Q, Yang X . CRISPR/Cas9-based genome engineering of zebrafish using a seamless integration strategy. FASEB J. 2018; 32(9):5132-5142. DOI: 10.1096/fj.201800077RR. View

Danysz W, Dekundy A, Scheschonka A, Riederer P . Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials. J Neural Transm (Vienna). 2021; 128(2):127-169. PMC: 7901515. DOI: 10.1007/s00702-021-02306-2. View

Lu F, Langenbacher A, Chen J . Tbx20 drives cardiac progenitor formation and cardiomyocyte proliferation in zebrafish. Dev Biol. 2016; 421(2):139-148. PMC: 5226859. DOI: 10.1016/j.ydbio.2016.12.009. View

Thisse C, Thisse B . High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc. 2008; 3(1):59-69. DOI: 10.1038/nprot.2007.514. View

Burdine R, Grimes D . Antagonistic interactions in the zebrafish midline prior to the emergence of asymmetric gene expression are important for left-right patterning. Philos Trans R Soc Lond B Biol Sci. 2016; 371(1710). PMC: 5104502. DOI: 10.1098/rstb.2015.0402. View

10.

Holtzinger A, Evans T . Gata4 regulates the formation of multiple organs. Development. 2005; 132(17):4005-14. DOI: 10.1242/dev.01978. View

11.

Scholz S, Fischer S, Gundel U, Kuster E, Luckenbach T, Voelker D . The zebrafish embryo model in environmental risk assessment--applications beyond acute toxicity testing. Environ Sci Pollut Res Int. 2008; 15(5):394-404. DOI: 10.1007/s11356-008-0018-z. View

12.

Auer T, Duroure K, De Cian A, Concordet J, Del Bene F . Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. Genome Res. 2013; 24(1):142-53. PMC: 3875856. DOI: 10.1101/gr.161638.113. View

13.

Lenhart K, Lin S, Titus T, Postlethwait J, Burdine R . Two additional midline barriers function with midline lefty1 expression to maintain asymmetric Nodal signaling during left-right axis specification in zebrafish. Development. 2011; 138(20):4405-10. PMC: 3177310. DOI: 10.1242/dev.071092. View

14.

Williams K, Carson J, Lo C . Genetics of Congenital Heart Disease. Biomolecules. 2020; 9(12). PMC: 6995556. DOI: 10.3390/biom9120879. View

15.

Hwang W, Fu Y, Reyon D, Maeder M, Tsai S, Sander J . Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol. 2013; 31(3):227-9. PMC: 3686313. DOI: 10.1038/nbt.2501. View

16.

NORA J, Nora A, Way G . Letter: Cardiovascular maldevelopment associated with maternal exposure to amantadine. Lancet. 1975; 2(7935):607. DOI: 10.1016/s0140-6736(75)90198-1. View

17.

Bakkers J . Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovasc Res. 2011; 91(2):279-88. PMC: 3125074. DOI: 10.1093/cvr/cvr098. View

18.

Rosa F . Amantadine pregnancy experience. Reprod Toxicol. 1994; 8(6):531. DOI: 10.1016/0890-6238(94)90036-1. View

19.

Cassar S, Adatto I, Freeman J, Gamse J, Iturria I, Lawrence C . Use of Zebrafish in Drug Discovery Toxicology. Chem Res Toxicol. 2019; 33(1):95-118. PMC: 7162671. DOI: 10.1021/acs.chemrestox.9b00335. View

20.

Pandit P, Chitayat D, Jefferies A, Landes A, Qamar I, Koren G . Tibial hemimelia and tetralogy of Fallot associated with first trimester exposure to amantadine. Reprod Toxicol. 1994; 8(1):89-92. DOI: 10.1016/0890-6238(94)90072-8. View